Overview

FAPI-74 PET/CT in Adults with Fibrosis

Status:
RECRUITING
Trial end date:
2027-07-30
Target enrollment:
Participant gender:
Summary
This protocol is intended as a basket protocol designed to evaluate the use of Fibroblast Activating Protein (FAP) PET/CT in imaging the presence of fibrosis caused by a variety of medical conditions where fibrosis is believed to lead to pathological effects and poor prognosis.
Phase:
PHASE1
Details
Lead Sponsor:
Abramson Cancer Center at Penn Medicine